AU4308300A - Pyrazoles having antiinflammatory activity - Google Patents
Pyrazoles having antiinflammatory activityInfo
- Publication number
- AU4308300A AU4308300A AU43083/00A AU4308300A AU4308300A AU 4308300 A AU4308300 A AU 4308300A AU 43083/00 A AU43083/00 A AU 43083/00A AU 4308300 A AU4308300 A AU 4308300A AU 4308300 A AU4308300 A AU 4308300A
- Authority
- AU
- Australia
- Prior art keywords
- pyrazoles
- antiinflammatory activity
- antiinflammatory
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN508MA1999 | 1999-05-03 | ||
IN508/MAS/99 | 1999-05-03 | ||
PCT/IB2000/000556 WO2000066562A1 (en) | 1999-05-03 | 2000-05-02 | Pyrazoles having antiinflammatory activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4308300A true AU4308300A (en) | 2000-11-17 |
Family
ID=11095418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43083/00A Abandoned AU4308300A (en) | 1999-05-03 | 2000-05-02 | Pyrazoles having antiinflammatory activity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4308300A (en) |
WO (1) | WO2000066562A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74539C2 (en) * | 1999-12-08 | 2006-01-16 | Pharmacia Corp | Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants) |
EP1150959B1 (en) | 1999-12-08 | 2008-02-27 | Pharmacia Corporation | Solid-state form of celecoxib having enhanced bioavailability |
ES2166710B1 (en) * | 2000-04-25 | 2004-10-16 | J. URIACH & CIA, S.A. | NEW HETEROCICLIC COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY. |
WO2003011316A1 (en) * | 2001-08-01 | 2003-02-13 | Altana Pharma Ag | Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome |
US6956052B2 (en) | 2001-09-19 | 2005-10-18 | Pharmacia Corporation | Substituted pyrazolyl compounds for the treatment of inflammation |
WO2003037330A1 (en) * | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors |
WO2003037335A1 (en) * | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | 5-heteroatom-substituted pyrazoles |
KR20050013553A (en) * | 2002-05-24 | 2005-02-04 | 파마시아 코포레이션 | Synthesis of diaryl pyrazoles |
US7211598B2 (en) * | 2002-06-28 | 2007-05-01 | Nitromed, Inc. | Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
CA2505945A1 (en) | 2002-12-02 | 2004-06-17 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazole derivatives useful as cox-i inhibitors |
GB0308318D0 (en) * | 2003-04-10 | 2003-05-14 | Merck Sharp & Dohme | Therapeutic agents |
AU2004232973A1 (en) * | 2003-04-18 | 2004-11-04 | Memory Pharmaceuticals Corporation | Pyrazole derivatives as phosphodiesterase 4 inhibitors |
WO2005061463A1 (en) | 2003-12-23 | 2005-07-07 | Astex Therapeutics Limited | Pyrazole derivatives as protein kinase modulators |
US7432266B2 (en) | 2004-10-15 | 2008-10-07 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
US8343953B2 (en) | 2005-06-22 | 2013-01-01 | Astex Therapeutics Limited | Pharmaceutical compounds |
JP5345842B2 (en) | 2005-06-23 | 2013-11-20 | アステックス・セラピューティクス・リミテッド | Pharmaceutical combinations containing pyrazole derivatives as protein kinase modulators |
GB0704932D0 (en) | 2007-03-14 | 2007-04-25 | Astex Therapeutics Ltd | Pharmaceutical compounds |
TWI435874B (en) | 2008-10-31 | 2014-05-01 | Toray Industries | A cyclohexane derivative and the medical and pharmaceutical use |
CN102822148B (en) * | 2010-03-31 | 2015-03-11 | 东丽株式会社 | Therapeutic agent or prophylactic agent for fibromyalgia |
MX2012010766A (en) * | 2010-03-31 | 2012-10-15 | Toray Industries | Therapeutic agent or preventive agent for urine collection disorder. |
PL2565184T3 (en) * | 2010-04-28 | 2016-06-30 | Toray Industries | Therapeutic agent and preventative agent for alzheimer's disease |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
WO2021074108A1 (en) * | 2019-10-16 | 2021-04-22 | Bayer Aktiengesellschaft | Process of preparing 1,1'-disulfandiylbis(4-fluoro-2-methyl-5-nitrobenzol) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE792587A (en) * | 1971-12-11 | 1973-06-12 | Hoechst Ag | AZOIC COLORANTS AND THEIR PREPARATION |
DE3420985A1 (en) * | 1983-10-15 | 1985-04-25 | Bayer Ag, 5090 Leverkusen | SUBSTITUTED 5-ACYLAMINO-1-PHENYLPYRAZOLE |
CN1061036C (en) * | 1993-11-30 | 2001-01-24 | G·D·瑟尔公司 | Substituted pyrazolyl benzenesulfonamides for treating inflammation |
IT1287174B1 (en) * | 1996-11-15 | 1998-08-04 | Angelini Ricerche Spa | PHARMACOLOGICALLY ACTIVE DIARYL-CYCLOMETHYLENPYRAZOLES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
TNSN99111A1 (en) * | 1998-06-11 | 2005-11-10 | Pfizer | NOVEL SULFONYLBENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
-
2000
- 2000-05-02 AU AU43083/00A patent/AU4308300A/en not_active Abandoned
- 2000-05-02 WO PCT/IB2000/000556 patent/WO2000066562A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000066562A1 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4308300A (en) | Pyrazoles having antiinflammatory activity | |
AU1173201A (en) | Skin-gripper | |
AU3092999A (en) | Digital-timeshare-exchange | |
AU6330099A (en) | Novel heterocyclyl-methyl-substituted pyrazoles | |
AU2678800A (en) | Modified calycins | |
AU5967600A (en) | Candystraw | |
AU6335000A (en) | Depthimeter | |
AU4115400A (en) | Short-circuiter | |
AU7514700A (en) | Cyanopiperidines | |
AU6440900A (en) | Homogentisate-dioxygenase | |
AU2804600A (en) | Arylaminoalkylamides | |
AU2023701A (en) | Sketcher | |
AU2699800A (en) | Organoceramics | |
AU6098300A (en) | Follistatin-3 | |
AU4916900A (en) | Benzofuranylsulfonates | |
AU3191100A (en) | Ligand-bonded complex | |
AU4561600A (en) | Benzofuranylaminoalcohols | |
AU1901801A (en) | Glucofuranoses | |
AU4625400A (en) | Connecting organ | |
AU2582200A (en) | Windturbine | |
AU4435300A (en) | Hula-hoop | |
AU7513400A (en) | Hydantoin-racemase | |
AU1915601A (en) | Periotome | |
AU7303400A (en) | Osseo-distractor | |
AU7462200A (en) | Loudspeaker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |